Cerulean Pharma Inc. CERU
No live quote for CERU yet.
- Market cap
- 19.04M
- P/E ratio
- -0.57
- Forward P/E
- -1.06
- Volume
- 6.24M
- Avg volume
- 217.76K
- Open
- 0.68
- Previous close
- 0.6309
- Analysts
- Strong Buy
- Price target
- 3.75
No chart data for this range yet.
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 6.88
- 200-day average
- 8.34
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 17, 2016 | Wedbush | down | — | Neutral |
| Aug 17, 2016 | Leerink Swann | down | — | Market Perform |
| Aug 17, 2016 | Janney Capital | down | — | Neutral |
| Aug 17, 2016 | JMP Securities | down | — | Market Perform |
| Jan 5, 2016 | Janney Capital | init | — | Buy |
| Sep 21, 2015 | Barclays | init | — | Overweight |
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CERU — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARBUCKLE STUART A | Director | Acquisition (Non Open Market) | Jan 2, 2017 | 13,104 |
| FRIEDMAN PAUL A | Director | Acquisition (Non Open Market) | Apr 2, 2017 | 18,819 |
| GUIFFRE CHRISTOPHERD T | Officer | Acquisition (Non Open Market) | Dec 30, 2016 | 12,489 |
| MCKEE WILLIAM | Director | Acquisition (Non Open Market) | Jan 2, 2017 | 3,418 |
| ONEILL JAMES E | Officer | Acquisition (Non Open Market) | Dec 30, 2015 | 2,098 |
| PARKINSON DAVID ROSS | Director | Acquisition (Non Open Market) | Jan 2, 2017 | 28,488 |